CMS 9123 P
FDA COVID-19 Vaccines EUA to Commercial Use
NCPDP Comments to OIG Re Anti-kickback Statute Safe Harbors
NCPDP Comments to CMS Re Anti-kickback Statute Safe Harbors
NCPDP Comments to Kentucky WC regarding Pharmacy Fee Schedule
NCPDP’s Elite Partners provide the highest level of support for the valuable work of NCPDP in advancing patient safety and interoperability. The following Elite Partners have demonstrated intense commitment to support NCPDP’s work, vision and core values.